Happe Spine designs and commercializes spinal implants built on its HAPPE (HydroxyApatite Porous PEEK) material platform, which enables monolithic implant porosity in PEEK for endplate-to-endplate osteointegration. The platform aims to deliver the porosity advantages typically available only in 3D-printed titanium while using PEEK. The company will apply the Series A proceeds to launch an innovative interbody spinal fusion implant, complete final regulatory testing, and obtain 510(k) approval. Happe Spine also plans to scale manufacturing and the production of implant and instrument inventory and to add several new strategic leadership and staff positions. The material platform was invented at the University of Notre Dame by Dr. Ryan K. Roeder; the company has three issued patents with additional patents pending, and Dr. Roeder serves as founder, CTO and a board member. The company is based in Grand Rapids, Michigan.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2021